Our Team



<< < 1 2

Michel Fortin


Michel Fortin, CPA, CA, ICD.D, B.A.A.


President and CEO, EVAH Corp.


A seasoned entrepreneur, Michel Fortin’s professional accreditations include CPA, CA, ICD.D, B.A.A. He has a Bachelor of Commerce from Sherbrooke University (1978) and has completed the Directors Education Program of the Institute of Corporate Directors, Rotman School of Management, from the University of Toronto (2018).

 

An excellent negotiator and developer, Michel Fortin is recognised for his creative strategic thinking, his strong communication skills, his flair to identify opportunities globally and an ability to raise the capital to fulfill them. He is currently President and CEO of EVAH Corp., a Canadian business platform that aims to develop sustainable technologies in Animal Health and sell them to major players in the space.

 

He was the chief architect of Prevtec Microbia’s business and ?nancial strategies from 2005 to 2019, from a start-up company spun out of academia to a successful business, active in markets globally, up to its sale to Elanco, the second largest Animal Health company in the world.

 

In past roles as a financial and business executive of fast-growing companies, Michel implemented debt and equity financings as well as IPOs. He also restructured a company with revenues of $15 million and 250 employees that was in serious financial difficulty. He negotiated and signed an exclusive global license for a new antibacterial fiber, acquired and refinanced the company.

 

Previously he was a partner of Fortin, Tremblay et Associés, specialized in management consulting and accounting. He is the current President of BIOQuébec, the Trade Association of life sciences companies in Québec.


 


Geneviève Guertin


Geneviève Guertin


Vice-President, Investments - Life Sciences, Fonds de solidarité FTQ


Ms. Guertin uses her over 20 years of professional experience in life sciences to lead a team of seven professionals dedicated exclusively to the field of biotechnology. She spent eight years on this same team as Director, Investment, Life Sciences, overseeing numerous investment projects in private and public companies and in specialised funds, both in the areas of development and venture capital.

 

Before joining the Fonds de solidarité des travailleurs (FTQ) in 2012, Geneviève Guertin was Investment Director, Life Sciences, at Société générale de financement du Québec.

 

Ms. Guertin holds a Master of Science in Administration from HEC Montréal and the Chartered Financial Analyst (CFA) designation. She has also been a member of the BIOQuébec board since 2018.



David Jarry


David Jarry, MSc, LL.M.


 BDO Montréal

 

Mr. Jarry is an entrepreneur, consultant, investor and corporate director. For more than two decades as leader and consultant in the public and private sectors, Mr. Jarry has had the privilege of leading hundreds of employees, has advised more than 400 multinationals and start-ups in 19 industry sectors across every region of the world in more than 75 countries. Drawing on his international expertise, Mr. Jarry advises senior executives and entrepreneurs to make effective business and financial decisions that lead to value creation.

 

Mr. Jarry began his career in consulting at CIRANO as Director of project valuation and then spent nearly a decade at Deloitte in consulting in Canada and Europe. Mr. Jarry then took a leadership role at Prometic, a high-growth, international public company in the life sciences industry. Then, he returned to consulting for the fifth largest consulting firm in Canada as a Senior Partner and leader of international tax in Quebec at MNP. Mr. Jarry has served on several strategic and executive initiative committees at MNP. Among others, he was a member of the firm's executive committee for national tax, leader of the Canada's Top 40 Under 40 program for Eastern Canada, members of the leadership team for the province of Quebec for the technology, media and telecommunications and agrifood sectors. He was also Vice President of North American International Tax as well as Chairman of the Global Tax Business Development Committee of the Praxity Alliance, the world’s largest alliance of independent consulting firms which brings together more than 50,000 professionals and a combined turnover of over US$ 6 billion. Since 2018, he sits on the board of directors of Génome Québec and has been a member of its finance committee.

 

Mr. Jarry has developed a multidisciplinary expertise. His expertise includes strategic planning, business and project valuation, international mergers and acquisitions (due diligence, contract review, post-deal restructuring and post-merger integration, risk management), legal structures, international tax, international governance (private, public and not-for-profit), supply chain planning and reorganization, business restructuring, business plans, financial analysis, private and public financing and the valuation and protection of intellectual property.

 

Mr. Jarry has a College degree (DEC) in Creative Arts from Dawson College, a Bachelor (BSc) and a Master of Science (MSc) degree in economics from the Université de Montréal and a Master of Laws (LL.M.) degree from Maastricht University.


Marie-Paule Jeansonne


Marie-Paule Jeansonne, LL.B., MIA


President and Chief Executive Officer, Forum IA Québec

Marie-Paule holds a Master's in International Affairs, with a focus on international finance and economic policy, from Columbia University-SIPA, and a Bachelor of Laws from Université de Montréal. Marie-Paule took over the leadership of the Forum IA Québec after working on the adoption of research, science and innovation policies within the Quebec government. Previously, she was an engagement manager at McKinsey & Company and a commercial litigation lawyer at Davies Ward Phillips & Vineberg. Between 2016 and 2018, Marie-Paule took part in Québec’s first efforts to structure its rising AI ecosystem, and in the development of Quebec’s Life Sciences and Research and Innovation Strategies. Forum IA Quebec’s mission is to mobilize all of the AI ecosystem’s actors around a common goal: to maximize the economic and social benefits of AI for all of Quebec.



Sylvain Moineau


Sylvain Moineau, O.C., PhD, FRSC


Full Professor
Département de biochimie, de microbiologie et de bio-informatique
Université Laval

Professor Sylvain Moineau completed a Bachelor of Microbiology at Université Laval in 1987. He pursued his academic career at the same university and, in 1993, earned a PhD in Food Science. During his PhD, he also spent 18 months at North Carolina State University. He then pursued industrial postdoctoral work with Unilever, the Florida-based multinational.

 

In 1996, he returned to Université Laval as Assistant Professor in microbiology, where his research team studies the biology of phages and phage-resistance mechanisms, including work on CRISPR-Cas systems. In 2005, he earned his full professorship and he is now a Professor in the Department of Biochemistry, Microbiology and Bioinformatics at Université Laval.

 

He holds the Canada Research Chair in Bacteriophages and is the Curator of the Félix d’Hérelle Reference Center for Bacterial Viruses, the world largest collection of reference phages : www.phage.ulaval.ca.

 

His research group studies phage biology and phage-bacteria interactions. Among others, he has characterized mechanisms used by bacteria to resist phages, including his landmark work on CRISPR-Cas systems.

 

Prof. Moineau has won several teaching and research awards. In 2017, he was awarded the NSERC John C. Polanyi Award, the Canadian Society of Microbiologists Murray Award for Career Achievement and the DuPont Excellence Medal. He was elected to the Academy of Sciences of the Royal Society of Canada and appointed an Officer of the Order of Canada. Thomson Reuters and Clarivate Analytics have ranked him amongst the most cited microbiologists for the past five years.


Caroline Quach


Caroline Quach, MD, MSc, FRCPC, FSHEA, FCAHS, FAMMI


Professor, Departments of Microbiology, Infectious Diseases and Immunology, Department of Pediatrics, Université de Montréal

Dr. Caroline Quach is a professor in the Department of Microbiology, Infectious Diseases and Immunology and the Department of Pediatrics of Université de Montréal. She is an adjunct professor in the Department of Epidemiology, Biostatistics and Occupational Health at McGill University and a scientific collaborator at the School of Public Health at Université Libre de Bruxelles (ULB) in Brussels. She is the physician in charge of infection prevention and control at CHU Sainte-Justine where she also works as a pediatric infectious diseases specialist and medical microbiologist. Dr. Quach is a clinician-scientist, funded by the Fonds de recherche Québec – Santé (chercheuse boursière de mérite) and was recently awarded the Canada Research Chair, Tier 1 in Infection Prevention and Control. Her research interests are in infection prevention both healthcare-associated and vaccine-preventable diseases.

 

Dr. Quach was Chair of the National Advisory Committee on Immunization from the Public Health Agency of Canada. She is a former president of the Association for Medical Microbiology and Infectious Diseases (AMMI) Canada (2014-2016). She was named Fellow of the Canadian Academy of Health Sciences and of the Society for Healthcare Epidemiology of America. Dr. Quach was selected as one of the 2019 most powerful women in Canada (2019 Top 100 Award Winner in the Manulife Science and Technology category).



Rémi Quirion


Rémi Quirion, PhD, CQ, O.C., FRSC


Chief Scientist of Québec

 

Professor Rémi Quirion is Chief Scientist of Québec following the implementation of Bill 130 on July 1, 2011, which merged Québec’s three research funds. A full professor in McGill’s Department of Psychiatry, Professor Quirion served as Scientific Director at the Douglas Mental Health University Institute from 1996 to 2011. In April 2009, he took up the position of Vice Dean (Life Sciences and Strategic Initiatives), Faculty of Medicine, as well as Senior University Advisor (Health Sciences Research) at McGill University, in addition to serving as the CIHR Executive Director, International Collaborative Research Strategy for Alzheimer's Disease. He withdrew from these positions following his nomination as Québec’s Chief Scientist.

 

Since 1996, under his leadership, the Douglas Research Centre became a premier research facility in Canada in the fields of neurosciences and mental health. Professor Quirion promoted the development of neurosciences and clinical research in neurology and psychiatry, as well as the social aspects and evaluation of research in mental health and addiction. His research interests include: a) understanding the relationships between key phenotypes of the Alzheimer's brain and b) molecular and pharmacological features of neuropeptide receptors focusing on NPY and CGRP, and their role in memory, pain and drug dependence, and in animal models of schizophrenia.He has a keen interest for training the next generation of scientists, having mentored over 20 doctoral students and 50 postdoctoral students, who currently work around the world. In addition to sitting on the advisory boards of over 15 scientific journals in psychiatry, pharmacology, and neurosciences, Professor Quirion has published 5 books, over 600 scientific papers and articles.

 

From 2000 to 2009, Professor Quirion was the first Scientific Director of the Institute of Neurosciences, Mental Health and Addiction (INMHA), one of the 13 virtual institutes of the Canadian Institutes of Health Research created in 2000. He is also one of the most highly cited neuroscientists in the world and a Fellow of the Royal Society of Canada. In 2003, he was named “Chevalier” of the Ordre national du Québec and received the Médaille de l’Assemblée nationale du Québec and the First Annual Award – National Mental Health Champion (Research). In 2004, he was honoured with the Québec Wilder-Penfield Award, the highest distinction in biomedical research in Québec as well as the Heinz Lehmann Award of the Douglas Hospital Foundation and the Dr. Mary V. Seeman Award from the Canadian Psychiatric Research Foundation. In 2005, he was appointed Fellow of the Canadian Academy of Health Sciences here at home and awarded an Honoris Causa Doctorate from the Central South University of China, Changsha, Hunan, which ranks among the country’s top 15 universities out of 2000; he also became a member of this university’s Academic Committee, a mandate that lasted until December 2010.

 

In 2007 Professor Quirion became a Member of the Order of Canada (O.C.) in recognition of his prolific scientific career. His latest distinctions include the Schizophrenia Society of Canada’s 2007 Pacesetter Award; the Canadian College of Neuropharmacology 2007 Medal for his exemplary career and exceptional contribution to neuropsychopharmacology in Canada through training, education and administration; the 2007 Prix Michel Sarrazin of the Club de recherches cliniques du Québec and the Verdun “Tip of the Hat” prize for international distinction awarded by the Verdun Economic Forum. In 2010 Professor Quirion was honoured with an Honoris Causa Doctorate from the Institut National de la Recherche in Québec City and in 2011 received yet another Honoris Causa Doctorate, Honorary Doctor of Laws, this time from Montréal’s Concordia University.


Jennifer Stoddart


Jennifer Stoddart, O.C., Ad. É.


Invited Scholar, Centre of Genomics and Policy, McGill University


Jennifer Stoddart was Canada’s privacy commissioner from December 2003 until December 2013. Early in her mandate, she recognized that to remain relevant as Canada’s privacy guardian, the Office of the Privacy Commissioner of Canada needed to focus attention on the online world. She also worked to raise awareness among Canadians of their privacy rights through enhanced communications, outreach, and research activities. Recognizing Canada’s international trade patterns, she also became involved in global privacy issues through her work with international organizations such as the OECD and the Asia-Pacific Economic Cooperation, which are examining ways to protect and enhance privacy rights on a global scale.

 

Jennifer Stoddart was the 2010 recipient of the International Association of Privacy Professionals’ Privacy Vanguard Award, and in June 2011, the Québec Bar awarded her the distinctions of Avocat émérite and Mérite Christine-Tourigny. She also received the Ontario Bar Association’s 2010 Karen Spector Memorial Award for Excellence in Privacy Law, and in 2009, she was awarded the Université du Québec à Montréal’s Prix Reconnaissance for her work protecting the privacy rights of Canadians. In 2012, the Washington-based Electronic Privacy Information Center awarded her its International Privacy Champion Award, and in 2011, Canadian Lawyer magazine named Jennifer Stoddart to its list of the “Top 25 Most Influential” in the justice system and legal profession in Canada. 


Ms. Stoddart was appointed Officer of the Order of Canada in December 2015, “for her international leadership in privacy rights and for her exemplary public service as the privacy commissioner of Canada.”

 
Jennifer Stoddart has served on the steering committee of the Group of Heads of Federal Agencies, a network comprising the chief executive officers of more than 100 federal agencies, boards, commissions, tribunals and Crown corporations. She also presided the Commission d’accès à l’information du Québec. While in this position, she published a report entitled The Choice of Transparency that led to important changes to Québec’s access to information and data protection legislation mandating that government departments and agencies make more information available to citizens. She has held several senior positions in public administration for the Governments of Québec and Canada since being called to the Québec Bar in 1981.

 
Ms. Stoddart holds a bachelor of civil law degree from McGill University, a master of arts in history from the University of Québec at Montréal, and a bachelor of arts from the University of Toronto’s Trinity College.


<< < 1 2